 |
ibrutinib |
|---|---|
| Trade Name | Imbruvica |
| Orphan Indication | Patients with extranodal marginal zone lymphoma (mucosa associated lymphoid tissue [MALT type] lymphoma) |
| USA Market Approval | USA |
| USA Designation Date | 2016-02-02 00:00:00 |
| Sponsor | Pharmacyclics, LLC;995 E. Arques Avenue;Sunnyvale, California, 94085 |
